MIG
ADVM

Mariner Investment Group’s Adverum Biotechnologies ADVM Stock Holding History

Mariner Investment Group’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-6,900
Closed -$1.12M – 197
2015
Q2 		$1.12M Buy
6,900
+5,400
+360% +$1.82M 0.29% 106
2015
Q1 		$608K Buy
+1,500
New +$634K 0.16% 117

Other funds holding ADVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Mariner Investment Group's ADVM Position: Q3 2015 in Review

Mariner Investment Group sold out of Adverum Biotechnologies (ADVM) in Q3 2015, closing a stake of 6,900 shares — an estimated $1.12M sold.

Mariner Investment Group first reported a position in ADVM in Q1 2015 and held it in 2 quarters. The position peaked at $1.12M in Q2 2015. 92 funds tracked by Wall St. Rank hold ADVM as of Q3 2015.

  • Mariner Investment Group reported no remaining Adverum Biotechnologies position as of Q3 2015 after selling out during the quarter.
  • Mariner Investment Group sold 6,900 Adverum Biotechnologies shares in Q3 2015, an estimated $1.12M.
  • Mariner Investment Group first reported a position in Adverum Biotechnologies in Q1 2015 and held it in 2 quarters.
  • Mariner Investment Group's Adverum Biotechnologies position peaked at $1.12M in Q2 2015.
  • 92 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q3 2015.

Based on Mariner Investment Group's 13F filing for Q3 2015, filed 6 Nov 2015.